3,128
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Clinical Characteristics of Non-Smoking Chronic Obstructive Pulmonary Disease Patients: Findings from the KOCOSS Cohort

, , , , , ORCID Icon, , , & show all
Pages 174-181 | Received 05 Nov 2021, Accepted 17 Feb 2022, Published online: 07 Apr 2022

References

  • Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006;27(2):397–412. DOI:10.1183/09031936.06.00025805
  • Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. DOI:10.1164/rccm.201204-0596PP
  • Halbert RJ, Isonaka S, George D, et al. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest. 2003;123(5):1684–1692. DOI:10.1378/chest.123.5.1684
  • Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the global burden of disease study 2015. Lancet Respir Med. 2017;5(9):691–706. DOI:10.1016/s2213-2600(17)30293-x
  • Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet Respir Med. 2020;8(6):585–596. DOI:10.1016/s2213-2600(20)30105-3
  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD, global initiative for chronic obstructive lung disease 2021. Available from: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf. Accessed December 23, 2020.
  • López-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23. DOI:10.1111/resp.12660
  • Kim C, Kim Y, Yang D-W, et al. Direct and indirect costs of chronic obstructive pulmonary disease in Korea. Tuberc Respir Dis (Seoul). 2019;82(1):27–34. DOI:10.4046/trd.2018.0035
  • Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977;1(6077):1645–1648. DOI:10.1136/bmj.1.6077.1645
  • Takiguchi H, Takeuchi T, Niimi K, et al. Proportion and clinical characteristics of non-asthmatic non-smokers among adults with airflow obstruction. PLoS One. 2018;13(5):e0196132. DOI:10.1371/journal.pone.0196132
  • Martinez FJ, Han MK, Allinson JP, et al. At the root: Defining and halting progression of early chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;197(12):1540–1551. DOI:10.1164/rccm.201710-2028PP
  • Regan EA, Hokanson JE, Murphy JR, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD. 2010;7(1):32–43. DOI:10.3109/15412550903499522
  • Lee SH, Hwang ED, Lim JE, et al. The risk factors and characteristics of COPD among nonsmokers in Korea: an analysis of KNHANES IV and V. Lung. 2016;194(3):353–361. DOI:10.1007/s00408-016-9871-6
  • Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374(9691):733–743. DOI:10.1016/S0140-6736(09)61303-9
  • Zhou Y, Wang C, Yao W, et al. COPD in Chinese nonsmokers. Eur Respir J. 2009;33(3):509–518. DOI:10.1183/09031936.00084408
  • Denguezli M, Daldoul H, Harrabi I, et al. COPD in nonsmokers: reports from the Tunisian population-based burden of obstructive lung disease study. PLoS One. 2016;11(3):e0151981. DOI:10.1371/journal.pone.0151981
  • Zhang J, Lin XF, Bai CX. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study. Int J Chron Obstruct Pulmon Dis. 2014;9:57–63. DOI:10.2147/copd.S52416
  • Ji W, Lim MN, Bak SH, et al. Differences in chronic obstructive pulmonary disease phenotypes between non-smokers and smokers. Clin Respir J. 2018;12(2):666–673. DOI:10.1111/crj.12577
  • Salvi SS, Brashier BB, Londhe J, et al. Phenotypic comparison between smoking and non-smoking chronic obstructive pulmonary disease. Respir Res. 2020;21(1):50. DOI:10.1186/s12931-020-1310-9
  • The Korea COPD Subgroup Study. Available from: http://www.kocoss.kr/.
  • Lee JY, Chon GR, Rhee CK, et al. Characteristics of patients with chronic obstructive pulmonary disease at the first visit to a pulmonary medical center in Korea: the Korea COPD subgroup study team cohort. J Korean Med Sci. 2016;31(4):553–560. DOI:10.3346/jkms.2016.31.4.553
  • Mullerova H, Shukla A, Hawkins A, et al. Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study. BMJ Open. 2014;4(12):e006171. DOI:10.1136/bmjopen-2014-006171
  • Choi JY, Yoon HK, Park SJ, et al. Chronic bronchitis is an independently associated factor for more symptom and high-risk groups. Int J Chron Obstruct Pulmon Dis. 2016;11:1335–1341. DOI:10.2147/copd.S105516
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. DOI:10.1183/09031936.05.00034805
  • Choi JK, Paek D, Lee JO. Normal predictive values of spirometry in Korean population. Tuberc Respir Dis. 2005;58(3):230–242. DOI:10.4046/trd.2005.58.3.230
  • Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet. 2001;358(9285):903–911. DOI:10.1016/s0140-6736(01)06075-5
  • Mauvais-Jarvis F, Bairey Merz N, Barnes PJ, et al. Sex and gender: modifiers of health, disease, and medicine. Lancet. 2020;396(10250):565–582. DOI:10.1016/s0140-6736(20)31561-0
  • Oh JY, Lee YS, Min KH, et al. Osteoporosis in patients with asthma–chronic obstructive pulmonary disease overlap syndrome. Tuberc Respir Dis. 2018;81(1):73–79. DOI:10.4046/trd.2017.0066
  • Bui DS, Lodge CJ, Burgess JA, et al. Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life. Lancet Respir Med. 2018;6(7):535–544. DOI:10.1016/S2213-2600(18)30100-0
  • Choi JY, Rhee CK. Diagnosis and treatment of early chronic obstructive lung disease (COPD). JCM. 2020;9(11):3426. DOI:10.3390/jcm9113426
  • Zhao D, Zhou Y, Jiang C, et al. Small airway disease: a different phenotype of early stage COPD associated with biomass smoke exposure. Respirology. 2018;23(2):198–205. DOI:10.1111/resp.13176
  • Rivera RM, Cosio MG, Ghezzo H, et al. Comparison of lung morphology in COPD secondary to cigarette and biomass smoke. Int J Tuberc Lung Dis. 2008;12(8):972–977.
  • Behrendt CE. Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. Chest. 2005;128(3):1239–1244. DOI:10.1378/chest.128.3.1239
  • Birring SS, Brightling CE, Bradding P, et al. Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study. Am J Respir Crit Care Med. 2002;166(8):1078–1083. DOI:10.1164/rccm.200203-245oc
  • Penña VS, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest. 2000;118(4):981–989. DOI:10.1378/chest.118.4.981
  • Lamprecht B, Schirnhofer L, Kaiser B, et al. Non-reversible airway obstruction in never smokers: results from the Austrian BOLD study. Respir Med. 2008;102(12):1833–1838. DOI:10.1016/j.rmed.2008.07.007
  • Kweon S, Kim Y, Jang MJ, et al. Data resource profile: the Korea national health and nutrition examination survey (KNHANES). Int J Epidemiol. 2014;43(1):69–77. DOI:10.1093/ije/dyt228
  • Brakema EA, van Gemert FA, van der Kleij R, et al. COPD’s early origins in low-and-middle income countries: what are the implications of a false start? NPJ Prim Care Respir Med. 2019;29(1):6. DOI:10.1038/s41533-019-0117-y
  • Myong JP, Yoon HK, Rhee CK, et al. Risk factors for lung function impairment among the general non-smoking Korean population. Int j Tuberc Lung Dis. 2015;19(9):1019–1026. DOI:10.5588/ijtld.14.0929
  • Korea National Health & Nutrition Examination Survey. Available from: https://knhanes.cdc.go.kr/knhanes/eng/index.do.
  • Jia G, Lu M, Wu R, et al. Gender difference on the knowledge, attitude, and practice of COPD diagnosis and treatment: a national, multicenter, cross-sectional survey in China. COPD. 2018;13:3269–3280. DOI:10.2147/COPD.S176173
  • Choi JY, Kim SY, Lee JH, et al. Clinical characteristics of chronic obstructive pulmonary disease in female patients: findings from a KOCOSS cohort. Int J Chron Obstruct Pulmon Dis. 2020;15:2217–2224. DOI:10.2147/copd.S269579